{'fraction_non_alphanumeric': 0.0322234156820623, 'fraction_numerical': 0.007518796992481203, 'mean_word_length': 4.648484848484848, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Haemolytic disease of the newborn foal1: Haemolytic disease of the newborn: comparative aspects in man and foal.

During the past two years we have been investigating problems in haemolytic disease of the newborn foal (HDNF), the initial aim being the prevention of the disease by a method similar to that which has been found effective in Rh haemolytic disease in man i.e. the injection of the mother post partum with anti-D immunoglobulin. The team consists of C A Clarke, W T A Donohoe, T M D Gimlette, R Hutcheon and HE Ritchie (University of Liverpool) ; A M Scott (Equine Research Station, Newmarket); and R T Maxwell (Caernarvon and Anglesey Hospital, Bangor). This paper and those by Gimlette (p 576) and Scott (p 581) show that we have been sidetracked from our principal aim because of a series of observations which suggest that naturally-occurring protective mechanisms are much more prevalent in the horse than in man.